The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / September / A Dual Approach for Pterygium Removal
Anterior Segment Cornea Opinions

A Dual Approach for Pterygium Removal

Optimizing pterygium removal with conjunctival autograft and amniotic membrane graft

By Himani Goyal 9/7/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Clinical Scorecard: A Dual Approach for Pterygium Removal

At a Glance

CategoryDetail
ConditionPterygium
Key MechanismsFibrovascular conjunctival tissue encroaches onto the cornea, influenced by UV radiation and other factors.
Target PopulationOlder patients, men, and those with dry eye disease or chronic irritation.
Care SettingOphthalmology surgical practice

Key Highlights

  • Pterygium prevalence is around 10%, higher in equatorial populations.
  • Recurrence rates after pterygium excision can be as high as 18%.
  • Combined conjunctival autograft and amniotic membrane graft shows recurrence rates of around 1%.
  • Inflammation management is crucial pre- and postoperatively.
  • Patient education on sun protection and postoperative care is essential.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis based on clinical examination of ocular surface changes.

Management

  • Surgical excision is definitive; consider combined CAG and AMG for better outcomes.

Monitoring & Follow-up

  • Monitor for recurrence and manage inflammation postoperatively.

Risks

  • Higher recurrence in males and patients under 40; consider alternative strategies in glaucoma patients.

Patient & Prescribing Data

Patients with symptomatic pterygium requiring surgical intervention.

Use topical steroids preoperatively and a regimen of prednisolone acetate and antibiotic drops postoperatively.

Clinical Best Practices

  • Utilize cryopreserved amniotic membranes for better healing outcomes.
  • Employ meticulous surgical techniques to minimize recurrence.
  • Educate patients on sun protection and postoperative care.

Related Resources & Content

  • Cryopreserved amniotic membrane using the TissueTuck technique
  • Pterygium: an update on pathophysiology, clinical features, and management
  • Recurrent pterygium: a review

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: